Mark S Forman
CIK 1922353 · Chief Medical Officer · last filed 2026-03-04
Mark S Forman is a Chief Medical Officer who has filed 12 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for VTYX, was dated Mar 4, 2026. Across all open-market trades the lifetime net is −$16.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $282.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$282.5K
2
12
-$16.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Ventyx Biosciences, Inc. (VTYX) Delisted | Chief Medical Officer | 0 | $13.99 | $0 | $0 | 5 | 2026-03-04 |
| PASG | CHIEF MEDICAL OFFICER | 48,631 | $5.81 | $282.5K | -$16.0K | 7 | 2024-03-19 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-04 | Ventyx Biosciences, Inc. (VTYX) Delisted | Disp (D) | −6,000 | $0 | EDGAR |
| 2025-11-19 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | +3,000 | $3.1K | EDGAR |
| 2025-05-16 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | +3,000 | $3.1K | EDGAR |
| 2025-01-03 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-08-13 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-19 | PASG | Grant (A) | — | $0 | EDGAR |
| 2024-02-13 | PASG | Mixed | +3,362 | -$1.6K | EDGAR |
| 2024-01-03 | PASG | Mixed | +34,187 | -$14.4K | EDGAR |
| 2023-04-05 | PASG | Grant (A) | — | $0 | EDGAR |
| 2022-11-14 | PASG | Grant (A) | — | $0 | EDGAR |